Detecting
longevity-enhancing compounds

Detecting
longevity-enhancing
Compounds

We use cutting-edge epigenetic technologies

Book a Call

Book a Call

Book a Call

Discover

Discover

Early & Late-Stage Pipeline
Discover additional longevity benefits to strengthen marketing position and expand indications

Enhance

Enhance

Database Asset Development
Secure rights to anonymized compound epigenetics data for drug discovery insight generation

EpiCompounds

EpiCompounds helps Biotech rapidly screen compounds to unlock longevity potential properties.

Get started

Get started

Get started

Our collaborations

How it works

We use cutting-edge epigenetic technologies like GrimAge and TIME-seq to screen libraries faster, cheaper, and with greater insight.

Step One

The compound is administered to the subject, a genetic sample is collected and analyzed using DNA methylation markers.

Step One

The compound is administered to the subject, a genetic sample is collected and analyzed using DNA methylation markers.

Step One

The compound is administered to the subject, a genetic sample is collected and analyzed using DNA methylation markers.

Step two

The readout is processed—markers are analyzed using epigenetic clock algorithms that estimate biological age, predicted time to death, and other relevant longevity indicators.

Step two

The readout is processed—markers are analyzed using epigenetic clock algorithms that estimate biological age, predicted time to death, and other relevant longevity indicators.

Step two

The readout is processed—markers are analyzed using epigenetic clock algorithms that estimate biological age, predicted time to death, and other relevant longevity indicators.

Step Three

Results delivered for decision (e.g., marketing, clinical trial, etc). See if a compound slows down or reverses biological aging—in weeks or months, not years.

Step Three

Results delivered for decision (e.g., marketing, clinical trial, etc). See if a compound slows down or reverses biological aging—in weeks or months, not years.

Step Three

Results delivered for decision (e.g., marketing, clinical trial, etc). See if a compound slows down or reverses biological aging—in weeks or months, not years.

Our mission driven founding team




Enable biopharma to utilize the full potential of their assets and accelerate the discovery of anti-aging drugs using epigenetic biomarkers for the benefit of patients and healthcare system


Guy Doron | Axel Gleizerman Copello

Book a Call

Book a Call

Contact